VA
In particular, Black veterans seen through an on-site program at a Philadelphia VA medical center were nearly five times more likely to get tested than through a telemedicine consult.
Less than 1 percent of patients treated at VA hospitals received an off-label therapy, and about a quarter of these patients responded to treatment.
Natera Awarded Contract to Provide Cancer Testing Services to VA
Natera will provide the VA with its Signatera circulating tumor DNA test for minimal residual disease assessment and treatment monitoring.
Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test
The test will be covered by the VA for five years to determine the risk of recurrence in early-stage lung cancer patients after surgery.
Grail, Veterans Affairs to Evaluate Galleri Cancer Early Detection Test
Grail will make Galleri available to 10,000 veterans, who may then participate in the company's observational REFLECTION study.
Jul 11, 2019
Mar 12, 2019